Prostatic Arterial Embolization for Control of Hematuria in Patients with Advanced Prostate Cancer

Jhih Wei Chen; Ji Hoon Shin; Teng Fu Tsao; Heung Gyu Ko; Hyun Ki Yoon; Ki Chang Han; Somrach Thamtorawat; Bumsik Hong

doi:10.1016/j.jvir.2016.10.010

Prostatic Arterial Embolization for Control of Hematuria in Patients with Advanced Prostate Cancer

Jhih Wei Chen
, Ji Hoon Shin
, Teng Fu Tsao
, Heung Gyu Ko
, Hyun Ki Yoon
, Ki Chang Han
, Somrach Thamtorawat
, Bumsik Hong

Department of Radiology

University of Ulsan College of Medicine
Chung Shan Medical University Hospital

Research output: Contribution to journal › Article › peer-review

40 Citations (Scopus)

Abstract

Nine patients with advanced prostate cancer (stage T4) underwent prostatic arterial embolization (PAE) for refractory prostatic hematuria. Angiograms showed prostatic neovascularity in all cases, and complete PAE was achieved in 8 cases (89% technical success rate). Gross hematuria ceased after PAE in 6 cases, translating to a 67% clinical success rate. There were no PAE-related complications. At 3-month follow-up, 2 cases showed recurrent hematuria, 4 patients had died from PAE-unrelated etiologies, and only 3 patients survived and were without gross hematuria. PAE could represent an alternative option for patients with advanced prostate cancer to control hematuria.

Original language	English
Pages (from-to)	295-301
Number of pages	7
Journal	Journal of Vascular and Interventional Radiology
Volume	28
Issue number	2
DOIs	https://doi.org/10.1016/j.jvir.2016.10.010
Publication status	Published - 1 Feb 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.jvir.2016.10.010

Cite this

@article{2908b7ad0da54b48995410a2a7b8a3a8,

title = "Prostatic Arterial Embolization for Control of Hematuria in Patients with Advanced Prostate Cancer",

abstract = "Nine patients with advanced prostate cancer (stage T4) underwent prostatic arterial embolization (PAE) for refractory prostatic hematuria. Angiograms showed prostatic neovascularity in all cases, and complete PAE was achieved in 8 cases (89\% technical success rate). Gross hematuria ceased after PAE in 6 cases, translating to a 67\% clinical success rate. There were no PAE-related complications. At 3-month follow-up, 2 cases showed recurrent hematuria, 4 patients had died from PAE-unrelated etiologies, and only 3 patients survived and were without gross hematuria. PAE could represent an alternative option for patients with advanced prostate cancer to control hematuria.",

author = "Chen, \{Jhih Wei\} and Shin, \{Ji Hoon\} and Tsao, \{Teng Fu\} and Ko, \{Heung Gyu\} and Yoon, \{Hyun Ki\} and Han, \{Ki Chang\} and Somrach Thamtorawat and Bumsik Hong",

note = "Publisher Copyright: {\textcopyright} 2016 SIR",

year = "2017",

month = feb,

day = "1",

doi = "10.1016/j.jvir.2016.10.010",

language = "English",

volume = "28",

pages = "295--301",

journal = "Journal of Vascular and Interventional Radiology",

issn = "1051-0443",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Prostatic Arterial Embolization for Control of Hematuria in Patients with Advanced Prostate Cancer

AU - Chen, Jhih Wei

AU - Shin, Ji Hoon

AU - Tsao, Teng Fu

AU - Ko, Heung Gyu

AU - Yoon, Hyun Ki

AU - Han, Ki Chang

AU - Thamtorawat, Somrach

AU - Hong, Bumsik

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Nine patients with advanced prostate cancer (stage T4) underwent prostatic arterial embolization (PAE) for refractory prostatic hematuria. Angiograms showed prostatic neovascularity in all cases, and complete PAE was achieved in 8 cases (89% technical success rate). Gross hematuria ceased after PAE in 6 cases, translating to a 67% clinical success rate. There were no PAE-related complications. At 3-month follow-up, 2 cases showed recurrent hematuria, 4 patients had died from PAE-unrelated etiologies, and only 3 patients survived and were without gross hematuria. PAE could represent an alternative option for patients with advanced prostate cancer to control hematuria.

AB - Nine patients with advanced prostate cancer (stage T4) underwent prostatic arterial embolization (PAE) for refractory prostatic hematuria. Angiograms showed prostatic neovascularity in all cases, and complete PAE was achieved in 8 cases (89% technical success rate). Gross hematuria ceased after PAE in 6 cases, translating to a 67% clinical success rate. There were no PAE-related complications. At 3-month follow-up, 2 cases showed recurrent hematuria, 4 patients had died from PAE-unrelated etiologies, and only 3 patients survived and were without gross hematuria. PAE could represent an alternative option for patients with advanced prostate cancer to control hematuria.

UR - https://www.scopus.com/pages/publications/85010192460

U2 - 10.1016/j.jvir.2016.10.010

DO - 10.1016/j.jvir.2016.10.010

M3 - Article

C2 - 28110760

AN - SCOPUS:85010192460

SN - 1051-0443

VL - 28

SP - 295

EP - 301

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

IS - 2

ER -

Prostatic Arterial Embolization for Control of Hematuria in Patients with Advanced Prostate Cancer

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this